EU Drugs Regulator Studying Expanded Use of COVID-19 Drug Remdesivir

(Reuters) —
A bottle containing the drug Remdesivir is held by a health worker. (Zsolt Czegledi/MTI via AP, File)

Europe’s drugs regulator said on Tuesday it is evaluating the use of remdesivir in COVID-19 patients who do not need oxygen support, after developer Gilead Sciences submitted an application to extend the medicine’s use.

Europe had conditionally approved remdesivir, sold under the brand name Veklury, in July for treating COVID-19 in adults and adolescents with pneumonia requiring oxygen support.

To Read The Full Story

Are you already a subscriber?
Click to log in!

Hamodia Logo